Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2008-07-22
2008-07-22
Ketter, James S (Department: 1636)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S459000
Reexamination Certificate
active
07402573
ABSTRACT:
The invention relates to the use of DNA-loaded nanoparticles for a transfection of DNA into cells in vitro or in vivo.
REFERENCES:
patent: 6248720 (2001-06-01), Mathiowitz et al.
patent: 6265546 (2001-07-01), Cohen et al.
patent: WO 00/74658 (2000-12-01), None
patent: WO 2004/017945 (2004-03-01), None
Verma et al., Nature, vol. 389, 1997, pp. 239-242.
Anderson, Nature, vol. 392, 1998, pp. 25-30.
Juengst, Brit. Med. J., vol. 326, 2003, pp. 1410-1411.
International Search Report dated Mar. 28, 2003.
Olbrich et al., “Cationic Solid-Lipid Nanoparticles Can Efficiently Bind and Transfect Plasmid DNA,”Journal of Controlled Release, vol. 77, No. 3, Dec. 13, 2001, pp. 345-355.
Sabel B. A.,“Forschungsthemen und-ziele,”Otto Von Guericke Universitat, XP002233638, Forschungsbericht 2001, p. 229.
Ringe Kerstin
Sabel Bernhard
Walz Christian
Jenkins Wilson Taylor & Hunt, P.A.
Ketter James S
NanoDel Technologies GmbH
LandOfFree
Use of nanoparticles for the DNA administration to a target... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of nanoparticles for the DNA administration to a target..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of nanoparticles for the DNA administration to a target... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2807525